Role of extracellular vesicles in castration-resistant prostate cancer.

Journal: Critical Reviews In Oncology/hematology
Published:
Abstract

Prostate cancer (PCa) is a common health threat to men worldwide, and castration-resistant PCa (CRPC) is the leading cause of PCa-related deaths. Extracellular vesicles (EVs) are lipid bilayer compartments secreted by living cells that are important mediators of intercellular communication. EVs regulate the biological processes of recipient cells by transmitting heterogeneous cargoes, contributing to CRPC occurrence, progression, and drug resistance. These EVs originate not only from malignant cells, but also from various cell types within the tumor microenvironment. EVs are widely dispersed throughout diverse biological fluids and are attractive biomarkers derived from noninvasive liquid biopsy techniques. EV quantities and cargoes have been tested as potential biomarkers for CRPC diagnosis, progression, drug resistance, and prognosis; however, technical barriers to their clinical application continue to exist. Furthermore, exogenous EVs may provide tools for new therapies for CRPC. This review summarizes the current evidence on the role of EVs in CRPC.

Authors
Chaoyu Liao, Zeyu Huang, Jingui Liu, Min Deng, Leyi Wang, Yutong Chen, Jia Li, Jiang Zhao, Xing Luo, Jingzhen Zhu, Qingjian Wu, Weihua Fu, Bishao Sun, Ji Zheng
Relevant Conditions

Prostate Cancer